Featured Posts
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
National Review
Telehealth Is Less Promising Than It First Seemed
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more…
Search Posts
News Release
Institute Welcomes Court Ruling on Commercial Free Speech
WASHINGTON, D.C., Dec. 4, 2012 – The Competitive Enterprise Institute applauded the U.S. Second Circuit Court of Appeals decision yesterday, concluding that the…
Hoover Institution
Free Speech for Big Pharma
One of the most important elements of medicine is also among the least well known: the ability of physicians to prescribe approved medicines for purposes…
Forbes
“Genetically Engineered” In California: A Food Label We Don’t Need
From “food miles” to farmers’ markets, it seems that consumers have never been more interested in the ways their food is grown. That’s one motivation…
Forbes
Labeling Of Genetically Engineered Foods Is A Losing Proposition
As Joe Six-pack munches Fritos and popcorn during the opening games of the NFL season, does he care what variety of corn was used to…
USA Today
FDA rules won’t do much good
Food-borne illnesses kill as many as 3,000 Americans each year, but consumers should not expect new Food and Drug Administration regulations to help. These rules,…
Real Clear Policy
More FDA Control Does Not Mean More Safety
News outlets are reporting that the U.S. Food and Drug Administration (FDA) has cited an alarmingly high number of alleged safety and regulatory violations by…